Regulatory Work to Secure Licence Variation for anastrozole
What the buyer wrote
This Tender is solely for the work involved to apply for and implement a major (type II) MHRA Marketing Authorisation variation to add a new clinical indication for anastrozole. The successful Bidder will be responsible for ensuring that all relevant MHRA conditions and documentation for the Marketing Authorisation variation are met and submitted within the time limits agreed with the Authority. In return the Authority will fund actual and reasonably incurred costs associated with obtaining this licence variation only.
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- Regulatory Work to Secure Licence Variation for anastrozole
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- services
- Where
- in Yorkshire and The Humber
- Kind of work
- Pharmacy and medicines
Who the buyer named
Russell Greeenwood was the named contact on this notice.